Literature DB >> 17970071

Nucleostemin expression in squamous cell carcinoma of the head and neck.

Zdenek Cada1, Jan Boucek, Barbora Dvoranková, Martin Chovanec, Jan Plzák, Roman Kodets, Jan Betka, Gian L Pinot, Hans-Joachim Gabius, Karel Smetana.   

Abstract

BACKGROUND: This study presents initial data on presence of nucleostemin--a nucleolar protein typical of stem cells in the normal squamous epithelium of the oropharynx and larynx - in squamous cell carcinoma originating from these epithelia.
MATERIALS AND METHODS: Differentiation and proliferation markers such as keratins, beta-catenin, galectin-1, and Ki-67 were studied in parallel with nucleostemin for defining cell characteristics.
RESULTS: Nucleostemin was detected in nucleoli of both proliferating basal cells and terminally differentiated suprabasal cells of normal epithelium and in tumor cells. Importantly, malignant transformation was connected with a significant enlargement of nucleostemin-positive nucleoli in these cell types.
CONCLUSION: Detection of nucleostemin in head and neck cancer cells, together with the size of nucleoli, may be important in the evaluation of tumor differentiation and biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970071

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Nucleostemin-like 1 is required for embryogenesis and leaf development in Arabidopsis.

Authors:  Xiaomin Wang; Bo Xie; Maosheng Zhu; Zhongming Zhang; Zonglie Hong
Journal:  Plant Mol Biol       Date:  2011-11-06       Impact factor: 4.076

2.  Guanine nucleotide binding protein-like 3 is a potential prognosis indicator of gastric cancer.

Authors:  Jing Chen; Shuang Dong; Jiangfeng Hu; Bensong Duan; Jian Yao; Ruiyun Zhang; Hongmei Zhou; Haihui Sheng; Hengjun Gao; Shunlong Li; Xianwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop.

Authors:  Dorothy Lo; Hua Lu
Journal:  Cell Cycle       Date:  2010-08-04       Impact factor: 4.534

4.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

5.  Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.

Authors:  P Nikpour; S J Mowla; S M Jafarnejad; U Fischer; W A Schulz
Journal:  Cell Prolif       Date:  2009-08-25       Impact factor: 6.831

6.  Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge.

Authors:  Sailay Siddiqi; Natalie Gude; Toru Hosoda; John Muraski; Marta Rubio; Gregory Emmanuel; Jenna Fransioli; Serena Vitale; Carola Parolin; Domenico D'Amario; Erik Schaefer; Jan Kajstura; Annarosa Leri; Piero Anversa; Mark A Sussman
Journal:  Circ Res       Date:  2008-06-02       Impact factor: 17.367

7.  Immunohistochemical study of doublecortin and nucleostemin in canine brain.

Authors:  E De Nevi; P Marco-Salazar; D Fondevila; E Blasco; L Pérez; M Pumarola
Journal:  Eur J Histochem       Date:  2013-03-20       Impact factor: 3.188

8.  Nucleostemin expression in invasive breast cancer.

Authors:  Takayuki Kobayashi; Kenkichi Masutomi; Kenji Tamura; Tomoyuki Moriya; Tamio Yamasaki; Yasuhiro Fujiwara; Shunji Takahashi; Junji Yamamoto; Hitoshi Tsuda
Journal:  BMC Cancer       Date:  2014-03-21       Impact factor: 4.430

9.  Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma.

Authors:  R Yoshida; H Nakayama; M Nagata; A Hirosue; T Tanaka; K Kawahara; Y Nakagawa; Y Matsuoka; J Sakata; H Arita; A Hiraki; M Shinohara; T Ito
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

10.  Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.

Authors:  Jan Boucek; Tomas Mrkvan; Martin Chovanec; Martin Kuchar; Jaroslav Betka; Vladimir Boucek; Marie Hladikova; Jan Betka; Tomas Eckschlager; Blanka Rihova
Journal:  J Cell Mol Med       Date:  2009-01-14       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.